Committee for Orphan Medicinal Products (COMP): 7-9 September 2021
EventHumanRare diseases
Date
Location
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
Agenda - COMP agenda of the 7-9 September 2021 meeting
COMP meeting report on the review of applications for orphan designation: September 2021
Minutes of the COMP meeting 7-9 September 2021